A stealth antigen SPESP1, which is epigenetically silenced in tumors, is a suitable target for cancer immunotherapy-Reference-Cited by-同舟云学术

A stealth antigen SPESP1, which is epigenetically silenced in tumors, is a suitable target for cancer immunotherapy

Published:2021-06-03 Issue:7 Volume:112 Page:2705-2713
ISSN:1347-9032
Container-title:Cancer Science
language:en
Short-container-title:Cancer Sci

Author:

Kosaka Akemi¹,Yajima Yuki¹,Hatayama Mayumi²,Ikuta Katsuya²,Sasaki Takaaki³^ORCID,Hirai Noriko³,Yasuda Syunsuke³,Nagata Marino¹,Hayashi Ryusuke⁴,Harabuchi Shohei⁴,Ohara Kenzo⁴,Ohara Mizuho¹,Kumai Takumi⁴^ORCID,Ishibashi Kei³,Hirata‐Nozaki Yui⁴,Nagato Toshihiro¹,Oikawa Kensuke¹,Harabuchi Yasuaki⁴,Celis Esteban⁵,Okumura Toshikatsu²,Ohsaki Yoshinobu³,Kobayashi Hiroya¹,Ohkuri Takayuki¹^ORCID

Affiliation:

1. Department of Pathology Asahikawa Medical University Asahikawa Japan

2. Division of Gastroenterology and Hematology/Oncology Department of Medicine Asahikawa Medical University Asahikawa Japan

3. Respiratory Center Asahikawa Medical University Asahikawa Japan

4. Department of Otolaryngology, Head and Neck Surgery Asahikawa Medical University Asahikawa Japan

5. Georgia Cancer Center Augusta University Medical College of Georgia Augusta GA USA

Funder

Japan Society for the Promotion of Science

Japan Agency for Medical Research and Development

Publisher

Wiley

Subject